About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Obesity and Weight Management in HFpEF: How Effective and Safe Are Weight-Loss Drugs?
By
Charleston HFpEF Virtual Conference: The Latest Knowledge on Heart Failure with preserved Ejection Fraction
FEATURING
Sheldon Litwin
June 15, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
01:52
Novo Nordisk – GLP-1 RA Therapy
T2D Treatment After Oral Agents: What Is the Next Step?
Feat.
C. Wierum,
L. Coco
Featured Video
08:19
Novo Nordisk – GLP-1 RA Therapy
T2D Treatment After Metformin: What Does This GLP-1 RA Head-to-Head Trial …
Feat.
R. Pratley
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almo…
Feat.
R. DeFronzo
12:18
Mayo Clinic Proceedings
Mortality Risk by BMI, Exercise Ability & Capacity in Stress Testing P…
Feat.
A. Rozanski
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a…
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combinatio…
Feat.
G. Umpierrez
17:16
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Approaches to Treating Diabetes that Reduce CV Events: How Effective Are D…
Feat.
J. Shen
20:56
Stanford Medicine
COVID-19 & Diabetes Treatment: Can We Reduce the Risk of Poorer Outcom…
Feat.
A. Peters
28:32
Weill Cornell Medicine Courses and Meetings
Hypothalamic Obesity
Feat.
B. Tchang
14:52
Richard Pratley
Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study
11:55
Cardiometabolic Health Congress (CMHC)
Highlights From CMHC Obesity Presentations: Panel Discussion on Preventing…
Feat.
H. Wyatt,
R. Eckel,
M. Look
09:24
Cardiometabolic Health Congress (CMHC)
SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Have We Learned From CV…
Feat.
R. Eckel
14:50
Robert Eckel
COVID-19 & Diabetes: How to Manage SGLT2, GLP-1 RAs, Metformin, ACE In…
11:31
Domenica Rubino
Weight Loss Maintenance for Adults With Once-Weekly Semaglutide: What Was …
27:50
Scripps Health: 2019 Updates in Diabetes Management
Management of Hyperglycemia: Impact on Complications in the CVOT Era
Feat.
D. Einhorn
06:12
Mayo Clinic Proceedings
Obesity Pharmacotherapy Trends in the United States
Feat.
F. Stanford
28:13
Scripps Health
2021 Pharmacotherapy for Obesity: Update on Weight Loss Medications for Ch…
Feat.
K. Nadolsky
15:12
Cardiometabolic Health Congress (CMHC)
Individualization of Treatment in T2DM Patients with CVD
Feat.
H. Bays
08:19
Novo Nordisk – GLP-1 RA Therapy
T2D Treatment After Metformin: What Does This GLP-1 RA Head-to-Head Trial …
Feat.
R. Pratley
17:59
Yale School of Medicine
High-Risk Pregnancy Management: Risk Factors, Antenatal Fetal Surveillance…
Feat.
M. Jane Minkin
